Cargando…

Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock

AIMS: Heart failure (HF) is an impending complication to myocardial infarction. We hypothesized that the degree of complement activation reflects severity of HF following acute myocardial infarction. METHODS AND RESULTS: The LEAF trial (LEvosimendan in Acute heart Failure following myocardial infarc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orrem, Hilde L., Nilsson, Per H., Pischke, Søren E., Grindheim, Guro, Garred, Peter, Seljeflot, Ingebjørg, Husebye, Trygve, Aukrust, Pål, Yndestad, Arne, Andersen, Geir Ø., Barratt‐Due, Andreas, Mollnes, Tom E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933968/ https://www.ncbi.nlm.nih.gov/pubmed/29424484 http://dx.doi.org/10.1002/ehf2.12266

Ejemplares similares

The alternative complement pathway is dysregulated in patients with chronic heart failure
por: Shahini, Negar, et al.
Publicado: (2017)

Association of Interleukin 8 and Myocardial Recovery in Patients with ST-Elevation Myocardial Infarction Complicated by Acute Heart Failure
por: Husebye, Trygve, et al.
Publicado: (2014)

Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure
por: Langseth, Miriam Sjåstad, et al.
Publicado: (2020)

Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
por: Barratt-Due, Andreas, et al.
Publicado: (2016)

IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
por: Orrem, Hilde L., et al.
Publicado: (2018)

Association of Ficolin-3 with Severity and Outcome of Chronic Heart Failure
por: Prohászka, Zoltán, et al.
Publicado: (2013)

Low fibre intake is associated with gut microbiota alterations in chronic heart failure
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2020)

Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
por: Askevold, Erik Tandberg, et al.
Publicado: (2015)

The Role of Complement in Liver Injury, Regeneration, and Transplantation
por: Thorgersen, Ebbe Billmann, et al.
Publicado: (2019)

Sacubitril/Valsartanstive Heart Failure: Cardiogenic Shock
por: Rawal, H. A., et al.
Publicado: (2018)

Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases—C3 or C5 emerge together with CD14 as promising targets
por: Barratt-Due, Andreas, et al.
Publicado: (2017)

Complement factor 5 blockade reduces porcine myocardial infarction size and improves immediate cardiac function
por: Pischke, Soeren E., et al.
Publicado: (2017)

Design of the GutHeart—targeting gut microbiota to treat heart failure—trial: a Phase II, randomized clinical trial
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2018)

Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice
por: Dhondup, Yangchen, et al.
Publicado: (2017)

The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure
por: Holt, Margrethe Flesvig, et al.
Publicado: (2021)

Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
por: Niyonzima, Nathalie, et al.
Publicado: (2020)

Pheochromocytoma Presenting as Acute Heart Failure Leading to Cardiogenic Shock and Multiorgan Failure
por: Steppan, Jochen, et al.
Publicado: (2011)

Increased Levels of Inflammatory Cytokines and Endothelin-1 in Alveolar Macrophages from Patients with Chronic Heart Failure
por: Sikkeland, Liv I. Bjoner, et al.
Publicado: (2012)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

The Value of Prolonged QRS in Patients with Heart Failure and Cardiogenic Shock
por: Jang, Se Yong, et al.
Publicado: (2020)

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
por: Holter, Jan C., et al.
Publicado: (2020)

Intracellular Complement Component 3 Attenuated Ischemia-Reperfusion Injury in the Isolated Buffer-Perfused Mouse Heart and Is Associated With Improved Metabolic Homeostasis
por: Torp, M-K., et al.
Publicado: (2022)

Activin A Levels Are Associated With Abnormal Glucose Regulation in Patients With Myocardial Infarction: Potential Counteracting Effects of Activin A on Inflammation
por: Andersen, Geir Ø., et al.
Publicado: (2011)

Extracorporeal Membrane Oxygenation as a Bridge for Heart Failure and Cardiogenic Shock
por: Zhong, Zhao-peng, et al.
Publicado: (2016)

Mechanical Circulatory Support for Acute Heart Failure Complicated by Cardiogenic Shock
por: Choi, Min Suk, et al.
Publicado: (2020)

Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
por: Awoyemi, Ayodeji, et al.
Publicado: (2021)

The Homeostatic Chemokine CCL21 Predicts Mortality and May Play a Pathogenic Role in Heart Failure
por: Yndestad, Arne, et al.
Publicado: (2012)

Heart failure and cardiogenic shock associated with the TB-immune reconstitution inflammatory syndrome
por: KENYON, CHRIS, et al.
Publicado: (2012)

Outcome differences in acute vs. acute on chronic heart failure and cardiogenic shock
por: Jones, Tara L., et al.
Publicado: (2020)

Predicting survival in patients with acute decompensated heart failure complicated by cardiogenic shock
por: Morici, Nuccia, et al.
Publicado: (2021)

Primary Cardiac Lymphoma Presenting with Thrombocytopenia, Right Heart Failure, and Cardiogenic Shock
por: Kurniawan, Samantha, et al.
Publicado: (2023)

Endotoxemia in Acute Heart Failure and Cardiogenic Shock: Evidence, Mechanisms and Therapeutic Options
por: Nguyen, Maxime, et al.
Publicado: (2023)

From Acute heart failure to cardiogenic shock patients requiring admission in ICU
por: Aissaoui, Nadia
Publicado: (2023)

Cytokines as new treatment targets in chronic heart failure
por: Damås, Jan Kristian, et al.
Publicado: (2001)

Sustained Toll-Like Receptor 9 Activation Promotes Systemic and Cardiac Inflammation, and Aggravates Diastolic Heart Failure in SERCA2a KO Mice
por: Dhondup, Yangchen, et al.
Publicado: (2015)

Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure
por: Rodenas‐Alesina, Eduard, et al.
Publicado: (2023)

Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression
por: Røe, Åsmund T, et al.
Publicado: (2019)

Complement C3c as a Biomarker in Heart Failure
por: Frey, A., et al.
Publicado: (2013)

Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
por: Garred, Peter, et al.
Publicado: (2021)

Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
por: Nendl, Andraž, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a2pe7uv3hag2dgumh8s5nib7hj